(Q34096269)

31 July 2017

1 reference

title

Antigen-specific therapy for autoimmune disease (English)

1 reference

31 July 2017

1 reference

2

Hafler DA

1 reference

31 July 2017

Harrison LC

1

1 reference

31 July 2017

1 December 2000

1 reference

Current Opinion in Immunology

31 July 2017

1 reference

31 July 2017

12

1 reference

31 July 2017

704-711

1 reference

31 July 2017

6

1 reference

Isolation of myelin basic protein-reactive T-cell lines from normal human blood

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Multiple levels of peripheral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Oral tolerance: mechanisms and therapeutic applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Systemic antigen in the treatment of T-cell-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Regulation of encephalitogenic T cells with recombinant TCR ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Specific vaccines against autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Copolymer 1 inhibits experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Oral tolerance in the treatment of inflammatory autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Cytokine regulation of T-cell function: potential for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

CD8 T-cells are not essential for the induction of "low-dose" oral tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Inductive events in oral tolerance in the TCR transgenic adoptive transfer model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Impaired mucosal immune responses in interleukin 4-targeted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

CD4+ but not CD8+ T cells are required for the induction of oral tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Inhibition of naïve class I-restricted T cells by altered peptide ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

DNA immunization to prevent autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

T cell design for therapy in autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900166-7

7 January 2021

10.1016/S0952-7915(00)00166-7

Identifiers

DOI

1 reference

release_rguvbz3d35ec3fndogyy573xb4

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rguvbz3d35ec3fndogyy573xb4

24 November 2022

mapped directly with Wikidata item

PubMed ID

11102776

1 reference

PubMed ID

11102776